Skip to Content
DiagnosticsDiagnostics
  • Article
  • Open Access

17 November 2026

18 Pages

Baseline Prostate Volume and the Magnitude and Durability of the Volumetric Response After Prostatic Artery Embolization: A Retrospective Ultrasound-Based Time-to-Event Analysis

,
,
,
,
and
1
Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Vienna, Austria
2
Rudolfinerhaus Private Clinic, Billrothstraße 78, 1190 Vienna, Austria
3
European Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141 Milan, Italy
*
Author to whom correspondence should be addressed.

Abstract

Background/Objectives: Whether the magnitude and durability of prostate volume reduction after prostatic artery embolization (PAE) depend on baseline gland size is unclear. Methods: Retrospective single-operator study at two institutions (2015–2024): 164 of 177 consecutive men treated by PAE for benign prostatic hyperplasia with evaluable transrectal ultrasound volumetry were stratified as small (30–65 mL, n = 53), medium (>65–100 mL, n = 70) or large (>100 mL, n = 41); median follow-up was 12.8 months. The primary endpoint was relative volume reduction at nadir. Durability was analysed in a 6-month landmark cohort of early responders (n = 87), with regrowth to ≥80% of baseline as an interval-censored event (Turnbull estimator; Cox regression on midpoint-imputed event times). Results: Median reduction at nadir was 41.7%, 40.1% and 39.1% in small, medium and large glands (p = 0.39); 10 patients (6.1%) never fell below 80% of baseline. Regrowth occurred in 27 of 87 landmark patients; the probability of sustained reduction 24 months after the landmark was 0.76 (95% confidence interval [CI] 0.61–0.88). Baseline volume was not significantly associated with durability (hazard ratio 0.97 per 10 mL, 95% CI 0.86–1.10), consistently across sensitivity analyses and after adjustment for 5-alpha-reductase inhibitor pretreatment, which was more than twice as common in large glands; in an exploratory analysis, deeper reduction by the landmark was associated with longer durability. Conclusions: No association between baseline volume and the magnitude or durability of the volumetric response was detected, but the confidence intervals are wide and do not exclude a clinically relevant effect. The durability estimates are conditional on an early volumetric response and continued follow-up and should not be generalised to the entire treated population; residual confounding by medical therapy cannot be excluded, and the findings concern prostate volume, not clinical efficacy.

Article Metrics

Citations

Article Access Statistics

Article metric data becomes available approximately 24 hours after publication online.